Abiopharma

🔍 AUBIN JEAN-PIERRE (Executive)

Company: BGC Group, Inc. (BGC)

Report Date: 2026-08-28

Detailed Transactions and Holdings:

• Sold 373,191 shares of Class A Common Stock, par value $0.01 per share at $12.12 per share (Direct)
  Date: 2026-08-28 | Code: D | equity_swap_involved: 0 | shares_owned_after: 1,082,071.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: On August 28, 2026, BGC Group, Inc. (the "Company") repurchased an aggregate of 373,191 shares of its Class A common stock, par value $0.01 per share ("Class A Common Stock"), beneficially owned by the reporting person. The sale price per share was the closing price per share of a share of the Class A Common Stock on the Nasdaq Global Select Market on August 28, 2026. The transaction was approved by the Audit Committee and Compensation Committee of the Board of Directors of the Company and was pursuant to the Company's existing stock buyback authorization and is exempt pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
• F2: Includes 207,999 shares of Class A Common Stock held directly.
• F3: Also includes 874,072 restricted stock units that each represent a contingent right to receive one share of Class A Common Stock ("RSUs") previously granted to the reporting person under the BGC Group, Inc. Long Term Incentive Plan, of which (i) 29,368 RSUs will vest on each of March 15, 2027, 2028 and 2029, (ii) 15,688 will vest on March 15, 2030, (iii) 349,158 RSUs will vest on July 1, 2033, in each case provided that the reporting person is still substantially providing services exclusively for the Company or any of its affiliates through the applicable vesting date,
• F4: (Continued from Footnote 3) (iv) 269,557 RSUs will vest ratably on each of the first (1st) through fifth (5th) anniversaries of April 1, 2026, provided that the reporting person is substantially providing services to the Company or any of its affiliates through the applicable vesting date, and contingent upon the Company, inclusive of its affiliates, generating at least $5 million in revenue for the quarter in which the vesting occurs, and (v) 151,565 RSUs will vest ratably over a period of four (4) years following the termination of the reporting person's employment with the Company.